Novel needle-free Intradermal (ID) delivery technologies provide effective alternatives to traditional Mantoux ID administration using needles.
An in-depth review of 59 published scientific manuscripts found that novel needle-free ID delivery technologies compared favorably to needles, demonstrating high acceptability among healthcare workers and caregivers, improved immunization coverage, and cost savings.
PharmaJet’s Tropis® ID Needle-free Injection System was identified as one of only two commercialized ID delivery technologies. Implementation research on Tropis is more extensive than the alternatives, and Tropis is the only technology in the review to achieve WHO-prequalification.